UCB S.A. ( UCBJY) - Key Metrics
UCBJY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $22.39 | $5.70 | $8.02 | $7.16 |
| 2025Q2 | $17.91 | $2.44 | $3.65 | $3.05 |
| 2024Q4 | $17.69 | $4.51 | $4.35 | $3.73 |
| 2024Q2 | $14.70 | $1.10 | $1.99 | $1.37 |
| 2023Q4 | $14.03 | $0.17 | $2.47 | $1.64 |
UCBJY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 10.46 |
| 2025Q2 | 55.58% | 17.11 |
| 2024Q4 | ? | 10.65 |
| 2024Q2 | 124.52% | 32.01 |
| 2023Q4 | ? | 117.39 |
UCBJY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 3.00% | ? |
| 2025Q2 | 1.82% | 0.81% |
| 2024Q4 | 1.94% | ? |
| 2024Q2 | 0.98% | 0.97% |
| 2023Q4 | 2.07% | ? |
UCBJY
Price: $151.43
Dividend Yield: 0.56%
Forward Dividend Yield: 0.33%
Payout Ratio: 106.59%
Dividend Per Share: 0.52 USD
Earnings Per Share: 3.99 USD
P/E Ratio: 36.57
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 57.4 billion
Average Dividend Frequency: 1
Years Paying Dividends: 17
DGR3: 8.72%
DGR5: 6.44%
DGR10: 4.51%